Andreas Rimner, MD
Dr. Rimner is a radiation oncologist and Scientific Director at the Comprehensive Cancer Center of Freiberg in Baden-Württemberg, Germany. He previously worked with a multidisciplinary team at Memorial Sloan Kettering Cancer Center to identify the best treatment options for patients diagnosed with thoracic cancers, like mesothelioma.
Education and Career
Dr. Rimner graduated from the Eberhard-Karls-Universität Tübingen medical school and then pursued his residency in Radiation Oncology at Memorial Sloan Kettering Cancer Center.
Board-certified in Radiation Oncology, he is the recipient of numerous awards and honors, including being named to Castle Connolly’s list of Top Doctors in the New York Metro Area and America’s Top Doctors; the ITMIG Barbara Nelbauer Award; and the IMIG New Young Investigator award. He is an Executive Board Member of the International Mesothelioma Interest Group.[1]
Dr. Rimner is currently a Vice Chair in the Department of Radiation Oncology at the University of Freiburg. He specializes in a wide range of malignancies, including lung cancer, mesothelioma, and thymic tumors, using state-of-the-art radiation techniques, including:[1]
- stereotactic body radiation therapy (SBRT)
- stereotactic ablative body radiation (SABR)
- stereotactic radiosurgery (SRS)
- intensity-modulated radiation therapy (IMRT)
- image-guided radiation therapy (IGRT)
- intensity-modulated pleural radiation therapy (IMPRINT)
- MR-guided radiation therapy
- proton radiation
He is skilled in these radiation technologies, which provide pinpoint accuracy in targeting cancers and limiting damage to surrounding healthy tissue
Research Interests
Dr. Rimner’s specific research interest is in improving imaging and the precision of radiation treatment delivery for patients with thoracic tumors.
He views combining radiation therapy with novel drugs such as immunotherapy and targeted therapies as the answer to rapidly advancing the field of thoracic oncology.
They are also conducting multiple studies on predictive biomarkers of outcome, side effects, and patient-reported quality of life using thoracic radiation therapy.[1]
Dr. Rimner bases his care of mesothelioma patients on helping them understand how radiation therapy works and what side effects they can expect. He believes that the quality of radiation oncology treatment depends in large part on the healthcare professional who has designed the treatment plan.
